Safety and Efficacy of Epitinib for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases: Open-Label Multicentre Dose-Expansion Phase Ib Study
- Resource Type
- Article
- Source
- In
Clinical Lung Cancer September 2022 23(6):e353-e361 - Subject
- Language
- ISSN
- 1525-7304